Tetraphase Pharmaceuticals' Series C Round

Tetraphase Pharmaceuticals raised a round of funding on May 19, 2010.

Tetraphase Pharmaceuticals discovers and develops new tetracycline antibiotics to treat drug resistant bacterial infections using technology developed by Dr. Andrew Myers Professor of Chemistry and Ch…

Articles about Tetraphase Pharmaceuticals' Series C Round: